본문 바로가기
KERD
논문KCI 등재

Recent Advances in Autism Spectrum Disorders: Applications of Whole Exome Sequencing Technology

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

주제분류정신과학

초록

Autism spectrum disorders (ASD) is characterized by three core symptoms with impaired reciprocal social interaction and communication, a pattern of repetitive behavior and/or restricted interests in early childhood. The prevalence is higher in male children than in female children. As a complex neurodevelopmental disorder, the phenotype and severity of autism are extremely heterogeneous with differences from one patient to another. Genetics has a key role in the etiology of autism. Environmental factors are also interacting with the genetic profile and cause abnormal changes in neuronal development, brain growth, and functional connectivity. The term of exome represents less than 1% of the human genome, but contains 85% of known disease-causing variants. Whole-exome sequencing (WES) is an application of the next generation sequencing technology to determine the variations of all coding regions, or exons of known genes. For this reason, WES has been extensively used for clinical studies in the recent years. WES has achieved great success in the past years for identifying Mendelian disease genes. This review evaluates the potential of current findings in ASD for application in next generation sequencing technology, particularly WES. WES and whole-genome sequencing (WGS) approaches may lead to the discovery of underlying genetic factors for ASD and may thereby identify novel therapeutic targets for this disorder.

Abstract

Autism spectrum disorders (ASD) is characterized by three core symptoms with impaired reciprocal social interaction and communication, a pattern of repetitive behavior and/or restricted interests in early childhood. The prevalence is higher in male children than in female children. As a complex neurodevelopmental disorder, the phenotype and severity of autism are extremely heterogeneous with differences from one patient to another. Genetics has a key role in the etiology of autism. Environmental factors are also interacting with the genetic profile and cause abnormal changes in neuronal development, brain growth, and functional connectivity. The term of exome represents less than 1% of the human genome, but contains 85% of known disease-causing variants. Whole-exome sequencing (WES) is an application of the next generation sequencing technology to determine the variations of all coding regions, or exons of known genes. For this reason, WES has been extensively used for clinical studies in the recent years. WES has achieved great success in the past years for identifying Mendelian disease genes. This review evaluates the potential of current findings in ASD for application in next generation sequencing technology, particularly WES. WES and whole-genome sequencing (WGS) approaches may lead to the discovery of underlying genetic factors for ASD and may thereby identify novel therapeutic targets for this disorder.

참고문헌 (72)

  1. Devlin B, "Genetic architecture in autism spectrum disorder", Curr Opin Genet Dev, 22, pp.229~237 (2012)
  2. Siniscalco D, "Epigenetic findings in autism : new perspectives for therapy", Int J Environ Res Public Health, 10, pp.4261~4273 (2013)
  3. Chung BH, "Copy number variation and autism : new insights and clinical implications", J Formos Med Assoc, 113, pp.400~408 (2014)
  4. Sener EF, "MTHFR gene C677T polymorphism in autism spectrum disorders", Genet Res Int, 2014, pp.698574~ (2014)
  5. Srivastava AK, "Intellectual disability and autism spectrum disorders : causal genes and molecular mechanisms", Neurosci Biobehav Rev, 46, pp.161~174 (2014)
  6. Canitano R, "Epilepsy in autism spectrum disorders", Eur Child Adolesc Psychiatry, 16, pp.61~66 (2007)
  7. Liu X, "Genomic and genetic aspects of autism spectrum disorder", Biochem Biophys Res Commun, 452, pp.244~253 (2014)
  8. Smith CL, "Genomic and epigenomic instability, fragile sites, schizophrenia and autism", Curr Genomics, 11, pp.447~469 (2010)
  9. Grabrucker AM, "Environmental factors in autism", Front Psychiatry, 3, pp.118~ (2013)
  10. Goldani AA, "Biomarkers in autism", Front Psychiatry, 5, pp.100~ (2014)
  11. Tordjman S, "Gene×Environment interactions in autism spectrum disorders : role of epigenetic mechanisms", Front Psychiatry, 5, pp.53~ (2014)
  12. Sener EF, "Association of copy number variations in autism spectrum disorders : a systematic review", Chinese J Biol, 2014, pp.1~9 (2014)
  13. Schanen NC, "Epigenetics of autism spectrum disorders", Hum Mol Genet, 15, pp.R138~R150 (2006)
  14. Schreiber M, "Next-generation sequencing in schizophrenia and other neuropsychiatric disorders", Am J Med Genet B Neuropsychiatr Genet, 162B, pp.671~678 (2013)
  15. Kato T, "Whole genome", exome sequencing in mood and psychotic disorders, 2015, pp.69, 65~76
  16. Han G, "Genomics in neurological disorders", Genomics Proteomics Bioinformatics, 12, pp.156~163 (2014)
  17. Rosti RO, "The genetic landscape of autism spectrum disorders", Dev Med Child Neurol, 56, pp.12~18 (2014)
  18. Doherty JL, "Genomic insights into the overlap between psychiatric disorders : implications for research and clinical practice", Genome Med, 6, pp.29~ (2014)
  19. Toma C, "Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations", Mol Psychiatry, 19, pp.784~790 (2014)
  20. Sanger F, "DNA sequencing with chain-terminating inhibitors", Proc Natl Acad Sci USA, 74, pp.5463~5467 (1977)
  21. Maxam AM, "A new method for sequencing DNA", Proc Natl Acad Sci U S A, 74, pp.560~564 (1977)
  22. van Dijk EL, "Ten years of next-generation sequencing technology", Trends Genet, 30, pp.418~426 (2014)
  23. França LT, "A review of DNA sequencing techniques", Q Rev Biophys, 35, pp.169~200 (2002)
  24. Rabbani B, "The promise of whole-exome sequencing in medical genetics", J Hum Genet, 59, pp.5~15 (2014)
  25. Yang Y, "Application of next-generation sequencing technology in forensic science", Genomics Proteomics Bioinformatics, 12, pp.190~197 (2014)
  26. International Human Genome Consortium, "Finishing the euchromatic sequence of the human genome", Nature, 431, pp.931~945 (2004)
  27. Behjati S, "What is next generation sequencing?", Arch Dis Child Educ Pract Ed, 98, pp.236~238 (2013)
  28. Day-Williams AG, "The effect of next-generation sequencing technology on complex trait research", Eur J Clin Invest, 41, pp.561~567 (2011)
  29. Moorthie S, "Review of massively parallel DNA sequencing technologies", Hugo J, 5, pp.1~12 (2011)
  30. Xuan J, "Next-generation sequencing in the clinic : promises and challenges", Cancer Lett, 340, pp.284~295 (2013)
  31. Kayman Kürekçi G, "Next-generation DNA sequencing technologies", Erciyes Med J, 36, pp.99~103 (2014)
  32. Shendure J, "Next-generation DNA sequencing", Nat Biotechnol, 26, pp.1135~1145 (2008)
  33. Pareek CS, "Sequencing technologies and genome sequencing", J Appl Genet, 52, pp.413~435 (2011)
  34. Desai AN, "Next-generation sequencing: ready for the clinics?", Clin Genet, 81, pp.503~510 (2012)
  35. Zhang X, "Exome sequencing greatly expedites the progressive research of Mendelian diseases", Front Med, 8, pp.42~57 (2014)
  36. Ku CS, "Exome versus transcriptome sequencing in identifying coding region variants", Expert Rev Mol Diagn, 12, pp.241~251 (2012)
  37. Ng SB, "Exome sequencing identifies the cause of a mendelian disorder", Nat Genet, 42, pp.30~35 (2010)
  38. Biesecker LG, "Exome sequencing makes medical genomics a reality", Nat Genet, 42, pp.13~14 (2010)
  39. Wang JL, "TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing", Brain, 133, pp.3510~3518 (2010)
  40. Hedges D, "Exome sequencing of a multigenerational human pedigree", PLoS One, 4, pp.e8232~ (2009)
  41. Kuhlenbäumer G, "Novel genomic techniques open new avenues in the analysis of monogenic disorders", Hum Mutat, 32, pp.144~151 (2011)
  42. Ng SB, "Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome", Nat Genet, 42, pp.790~793 (2010)
  43. Majewski J, "What can exome sequencing do for you?", J Med Genet, 48, pp.580~589 (2011)
  44. Ku CS, "Revisiting Mendelian disorders through exome sequencing", Hum Genet, 129, pp.351~370 (2011)
  45. Ezewudo M, "Evaluating rare variants in complex disorders using next-generation sequencing", Curr Psychiatry Rep, 15, pp.349~ (2013)
  46. Jouan L, "Rare variants in complex traits : novel identification strategies and the role of de novo mutations", Hum Hered, 74, pp.215~225 (2012)
  47. De Rubeis S, "Synaptic, transcriptional and chromatin genes disrupted in autism", Nature, 515, pp.209~215 (2014)
  48. Cukier HN, "Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders", Mol Autism, 5, pp.1~ (2014)
  49. Lee H, "Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation", Hum Mol Genet, 23, pp.3481~3489 (2014)
  50. Fukai R, "A case of autism spectrum disorder arising from a de novo missense mutation in POGZ", J Hum Genet, 60, pp.277~279 (2015)
  51. Yuen RK, "Whole-genome sequencing of quartet families with autism spectrum disorder", Nat Med, 21, pp.185~191 (2015)
  52. O’Roak BJ, "Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations", Nature Genet, 43, pp.585~589 (2011)
  53. Sanders SJ, "De novo mutations revealed by whole exome sequencing are strongly associated with autism", Nature, 485, pp.237~241 (2012)
  54. O’Roak BJ, "Sporadic autism exomes reveal a highly interconnected protein network Of de novo mutations", Nature, 485, pp.246~250 (2012)
  55. Neale BM, "Patterns and rates of exonic de novo mutations in autism spectrum disorders", Nature, 485, pp.242~245 (2012)
  56. Bi C, "Mutations of ANK3 identified by exome sequencing are associated with autism susceptibility", Hum Mutat, 33, pp.1635~1638 (2012)
  57. Chahrour MH, "Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism", PLoS Genet, 8, pp.e1002635~ (2012)
  58. Iossifov I, "De novo gene disruptions in children on the autistic spectrum", Neuron, 74, pp.285~299 (2012)
  59. Marchani EE, "Identification of rare variants from exome sequence in a large pedigree with autism", Hum Hered, 74, pp.153~164 (2012)
  60. Nava C, "Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE", Transl Psychiatry, 2, pp.e179~ (2012)
  61. Shi L, "Whole-genome sequencing in an autism multiplex family", Mol Autism, 4, pp.8~ (2013)
  62. Yu TW, "Using whole-exome sequencing to identify inherited causes of autism", Neuron, 77, pp.259~273 (2013)
  63. An JY, "Towards a molecular characterization of autism spectrum disorders: an exome sequencing and systems approach", Transl Psychiatry, 4, pp.e394~ (2014)
  64. Dong S, "De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder", Cell Rep, 9, pp.16~23 (2014)
  65. Ionita-Laza I, "Scan statistic-based analysis of exome sequencing data identifies FAN1 at 15q13.3 as a susceptibility gene for schizophrenia and autism", Proc Natl Acad Sci U S A, 111, pp.343~348 (2014)
  66. Lee H, "Exome sequencing identifies de novo gain of function missense mutation in KCND2 in identical twins with autism and seizures that slows potassium channel inactivation", Hum Mol Genet, 23, pp.3481~3489 (2014)
  67. Inoue E, "Rare heterozygous truncating variations and risk of autism spectrum disorder : whole-exome sequencing of a multiplex family and follow-up study in a Japanese population", Psychiatry Clin Neurosci, 69, pp.472~476 (2015)
  68. Butler MG, "Whole exome sequencing in females with autism implicates novel and candidate genes", Int J Mol Sci, 16, pp.1312~1335 (2015)
  69. Codina-Solà M, "Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders", Mol Autism, 6, pp.21~ (2015)
  70. Lozano R, "A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment", Eur J Hum Genet, 23, pp.1702~1707 (2015)
  71. gawa J, "Novel rare missense variations and risk of autism spectrum disorder: whole-exome sequencing in two families with affected siblings and a two-stage follow-up study in a Japanese population", PLoS One, 10, pp.e0119413~ (2015)
  72. Singleton AB, "Exome sequencing : a transformative technology", Lancet Neurol, 10, pp.942~946 (2011)

관련 논문AI추천

The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum DisorderJi Yeon Hong, Seung Min Bae대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2018 · 제16권 제2호Predicting Autism Spectrum Disorder Using Blood-based Gene Expression Signatures and Machine LearningDong Hoon Oh, Dong Hyun Ahn, Il Bin Kim, Seok Hyeon Kim대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2017 · 제15권 제1호Low-level brain somatic mutations in exonic regions are collectively implicated in autism with germline mutations in autism risk genes김준호, Jung Saehoon, Ju Young Seok, Kim Hyun Jung, Kim Il Bin, Kim Ja Hye, Kim Myeong-Heui, Kim Sanghyeon, Kim Sangwoo, Kim Woo Kyeong, Lee Jeong Ho, Lee Junehawk, Webster Maree J.생화학분자생물학회 · Experimental and Molecular Medicine2024 · 제56권 Polymorphism in the Promoter Region of SEMA5A Is Associated with Sociality Traits in Korean Subjects with Autism Spectrum Disorders김붕년, 김순애, 김재원, 박미라, 박태원, 손정우, 신민섭, 정운선대한신경정신의학회 · PSYCHIATRY INVESTIGATION2017 · 제14권 제6호Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism Spectrum Disorder박찬민, 반건호, 신찬영, 오수현, 유희정, 이아라, 이연정, 천근아, 홍민하대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2014 · 제12권 제1호Polymorphisms of BDNF Gene and Autism Spectrum Disorders: Family Based Association Study with Korean Trios김순애, 박미라, 양소영, 유희정, 조인희대한신경정신의학회 · PSYCHIATRY INVESTIGATION2014 · 제11권 제3호

이 간행물의 다른 논문 (6건)